Fluorescent in situ hybridizations were performed using the Tyramide amplification method (TSA) following the protocol described by Krabichler et al.73. At the beginning of the procedure, sections were incubated in a 3% hydrogene peroxide solution in 10% methanol, to inactivate endogenous peroxide. Also, after washing the sections with A and B solutions, two additional 5 min washes were performed using TNT (100 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.1% Tween 20 in filtered H2O). Then, sections were incubated at room temperature for 3 h in blocking solution (Blocking Buffer Reagent 1%, Heat Inactivated Horse Serum (HINHS) 1% in TNT). Finally, sections were incubated overnight in a new blocking solution containing the anti-Digoxigenin-POD, Fab fragment (Roche) (1/300) at 4ºC. The following day, sections were washed during 30 min at room temperature in TNT, followed by a 10 min wash in 0.05 M Borate Buffer, pH 8.5. Then, sections were incubated for 1 h, at room temperature in darkness, in a Biotin-tyramide (IRIS Biotech GmbH, Marktredwitz, Germany) solution (0.001% Biotin-tyramide and 0.0015% H2O2 in 0.05 M Borate, pH 8.5). After 3 washes in PBS, fluorescent label was obtained by 2-h incubation with Streptavidin-Alexa-546 (1/500) in PBS and 0,25% Tween 20.
IHC and FISH combined in the same sections was obtained by performing first the FISH protocol to continue with the immunoreaction as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.